
Researchers from Tel Aviv University (TAU) recently discovered a method to deliver neurological treatment to the human brain using an engineered version of Toxoplasma gondii, commonly known as “the cat parasite.”
One of the biggest challenges in treating neurological diseases is getting the therapeutic drugs through the blood-brain barrier (BBB).